Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Stopped early · Not applicable

Conditions studied: Central Serous Chorioretinopathy

In brief

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Key facts

Study ID

NCT01982383

Run by

George Washington University

People needed

2

Starts

2012-11-01

Expected to finish

2015-11-01

Last updated by the study team

2018-03-27

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with new diagnosis of CSC and no other comorbidities or prior retinal treatment
• Patients ranging from 30 to 60 years of age

You may not qualify if…

• Patients with no case of CSC
• Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration
• Patients with prior retinal treatment

Where it is running

• George Washington University Medical Faculty Associates — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.